Regarding the criticism that PVA imposes penalties on pharmaceutical companies that produce drugs with high public demand, the Ministry of Health and Welfare countered that it is a system that contributes to improving patient accessibility through new drug insurance.

The Ministry of Health and Welfare also said that it is impossible to temporarily suspend the implementation of PVA until the time when exchange rates and prices stabilize.

On the 17th, the Ministry of Health and Welfare responded to written questions about PVA by Baek Jong-heon and Lee Jong-sung of the National Assembly's Health and Welfare Committee.

Lawmaker Baek Jong-heon pointed out that cutting drug price